VINZENZ GRUPPE
     
 

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

Steger, GG, Greil, R, Lang, A, Rudas, M, Fitzal, F, Mlineritsch, B, Hartmann, BL, Bartsch, R, Melbinger, E, Hubalek, M, Stöger, H, Dubsky, P, Ressler, S, Petzer, AL, Singer, CF, Muss, C, Jakesz, R, Gampenrieder, SP, Zielinski, CC, Fesl, C and Gnant, M (2014) Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). [Fachpublikation (peer reviewed)]

Full text not available from this repository.
Item Type: Fachpublikation (peer reviewed)
Divisions: Ordensklinikum Linz Barmherzige Schwestern > Allgemeinchirurgie mit Viszeralchirurgie
Depositing User: Manuela Schühler
Date Deposited: 16 Jun 2014 07:30
Last Modified: 16 Jun 2014 07:30
URI: http://eprints.vinzenzgruppe.at/id/eprint/7136

Actions (login required)

View Item
View Item